Neurology Billing 2026: EMG/NCS, Neurosurgical Consults & Complex Coding Compliance

Neurology billing sits at the intersection of the most complex coding challenges in medicine. A single patient encounter can involve a high-complexity E/M visit, electrodiagnostic testing with multiple nerve conduction studies and needle EMG across several extremities, prolonged EEG monitoring, injectable drug administration, and care coordination spanning neurosurgery, rehabilitation, and primary care. Each of these services has its own CPT code logic, documentation requirements, LCD coverage criteria, and modifier rules — and getting any one of them wrong can unravel payment for the entire encounter.

Electrodiagnostic testing — EMG and nerve conduction studies — draws particularly intense payer scrutiny. Medicare Administrative Contractors across all jurisdictions maintain active Local Coverage Determinations governing when NCS and EMG are medically necessary, how many nerves can be tested per session, and what documentation must support each study. The OIG has identified electrodiagnostic billing as an area of heightened audit risk, with practices billing excessive numbers of nerve studies per encounter flagged for review.

This guide covers the neurology billing rules that matter most in 2026: EMG and NCS coding structure, EEG monitoring codes, neurosurgical consultation billing, high-complexity E/M documentation, the ICD-10 codes that drive neurology encounters, LCD compliance for electrodiagnostic services, and the denial prevention strategies that keep neurology practices compliant and fully reimbursed.

EMG and Nerve Conduction Study Coding

Electrodiagnostic testing generates two categories of CPT codes: nerve conduction studies (NCS) that measure the speed and amplitude of electrical signals through peripheral nerves, and needle electromyography (EMG) that evaluates muscle electrical activity at rest and during contraction. These are distinct services with separate codes, and both can be billed on the same date when medically necessary.

Nerve Conduction Study Codes

NCS codes are structured by the number of studies performed per encounter. Each 'study' represents a motor or sensory nerve tested at one site. The codes are tiered, and the practice bills the single code that corresponds to the total number of studies performed — not individual codes per nerve.

CPT Code	Studies Per Encounter	Work RVU	Description
95907	1–2 studies	0.50	Nerve conduction studies, 1–2 studies
95908	3–4 studies	0.96	Nerve conduction studies, 3–4 studies
95909	5–6 studies	1.39	Nerve conduction studies, 5–6 studies
95910	7–8 studies	1.77	Nerve conduction studies, 7–8 studies
95911	9–10 studies	2.13	Nerve conduction studies, 9–10 studies
95912	11–12 studies	2.46	Nerve conduction studies, 11–12 studies
95913	13+ studies	2.78	Nerve conduction studies, 13 or more studies

 

What Counts as One NCS Study

Each of the following counts as one study for NCS code selection: one motor nerve conduction test (including proximal and distal stimulation), one sensory nerve conduction test (antidromic or orthodromic), one F-wave test, and one H-reflex test. Late responses (F-waves) performed as part of a motor study count as a separate study. Understanding what constitutes a single study is critical for selecting the correct tiered code — overcounting inflates the code level and triggers audit flags, while undercounting leaves revenue uncaptured.

Needle EMG Codes

CPT Code	Description	Work RVU
95860	Needle EMG, 1 extremity (with or without paraspinal)	1.20
95861	Needle EMG, 2 extremities (with or without paraspinal)	1.85
95863	Needle EMG, 3 extremities (with or without paraspinal)	2.44
95864	Needle EMG, 4 extremities (with or without paraspinal)	2.97
95867	Needle EMG, cranial nerve innervated muscles, unilateral	0.76
95868	Needle EMG, cranial nerve innervated muscles, bilateral	1.16
95869	Needle EMG, thoracic paraspinal muscles	0.44
95870	Needle EMG, limited study (specific muscles)	0.60

 

Billing NCS and EMG Together

When both NCS and needle EMG are performed on the same date, both codes are reported — the appropriate NCS tiered code (95907–95913) plus the appropriate EMG extremity code (95860–95864). No modifier is needed to bill them together, as they are recognized as complementary components of a complete electrodiagnostic evaluation. However, documentation must clearly support the medical necessity for both types of testing, and the report must include separate findings for each component.

EEG Monitoring and Epilepsy Evaluation Codes

Electroencephalography codes cover a range of services from routine 20-minute EEGs to multi-day continuous monitoring in epilepsy monitoring units. EEG billing has become more complex as prolonged monitoring and ambulatory EEG studies have expanded beyond hospital settings.

CPT Code	Description	Work RVU	Setting
95816	EEG, including recording awake and asleep	1.44	Outpatient/inpatient
95819	EEG, including recording awake and drowsy	1.29	Outpatient
95812	EEG, extended monitoring, 41–60 minutes	1.86	Outpatient/inpatient
95813	EEG, extended monitoring, 61+ minutes	2.37	Outpatient/inpatient
95711	EEG continuous monitoring, each 24 hrs, with video (VEEG)	3.40	Inpatient epilepsy monitoring unit
95717	EEG continuous monitoring, each 24 hrs, without video	2.80	Inpatient
95720	Ambulatory EEG, recording and analysis, each 24 hrs	2.20	Outpatient/home

 

VEEG Monitoring: Documentation Requirements

Video-EEG monitoring (95711) is one of the highest-reimbursing neurology services, but it carries strict documentation requirements. The medical record must include the clinical indication for monitoring (typically seizure characterization or pre-surgical epilepsy evaluation), daily physician review notes documenting EEG interpretation and clinical correlation, identification of any seizure events captured with electrographic and clinical descriptions, and a final summary report at the conclusion of monitoring that synthesizes findings and clinical recommendations. Incomplete documentation during multi-day monitoring is a common audit finding — each 24-hour period billed must have corresponding physician interpretation documented.

Neurosurgical Consultation Billing

Neurology practices frequently coordinate care with neurosurgeons, and the billing rules for consultations versus transfers of care versus co-management create persistent confusion. Medicare eliminated separate consultation codes (99241–99245, 99251–99255) in 2010, but many commercial payers still recognize and reimburse them. Understanding which payer accepts which framework is essential for neurosurgical referral billing.

Medicare vs. Commercial Consultation Billing

Payer Type	Consultation Codes Accepted?	How to Bill
Medicare	No — use standard E/M codes	Bill 99202–99205 (new patient) or 99212–99215 (established) with appropriate modifier
Most Blue Cross Plans	Yes — use consultation codes	Bill 99242–99245 (office) or 99252–99255 (inpatient)
UnitedHealthcare	Yes — use consultation codes	Bill 99242–99245 (office) or 99252–99255 (inpatient)
Aetna	Yes — use consultation codes	Bill 99242–99245 (office) or 99252–99255 (inpatient)
Cigna	Varies by plan	Verify with specific plan before billing consultation codes
Medicaid	Varies by state	Check state-specific Medicaid rules for consultation code acceptance

 

Consultation Documentation Requirements

Regardless of which code set is used, a valid consultation requires three elements: a request from another physician for an opinion or advice on a specific clinical question, the consulting neurologist's evaluation and findings documented in a formal report, and a written communication back to the requesting physician with recommendations. If any of these three elements is missing, the service does not qualify as a consultation and must be billed as a standard new or established patient E/M visit.

Complex E/M Coding for Neurology Encounters

Neurology encounters frequently qualify for high-complexity E/M codes (99205/99215) because they involve multiple chronic conditions with overlapping treatment regimens, independent interpretation of advanced imaging and diagnostic studies, and management decisions carrying significant risk. The challenge is not that neurology visits lack complexity — it is that documentation often understates the actual work performed.

MDM Elements That Support High-Complexity Neurology Visits

MDM Element	High Complexity Criteria	Neurology Examples
Problems Addressed	1+ chronic illness with severe exacerbation, or acute condition threatening life/function	Uncontrolled epilepsy with breakthrough seizures; acute stroke evaluation; MS relapse with new neurologic deficits
Data Reviewed	Extensive — independent interpretation, external records, discussion with external physician	Independent MRI brain interpretation; review of outside EMG/NCS; phone discussion with neurosurgeon regarding surgical candidacy
Risk of Management	High — drug requiring intensive monitoring; decision about hospitalization; decision about emergency major surgery	Starting immunosuppressive therapy for MS; initiating anti-epileptic drug with hepatotoxicity risk; referring for deep brain stimulation evaluation

 

Prolonged Services in Neurology

Neurology encounters that extend beyond the typical time for the highest E/M level can capture additional revenue through prolonged service codes. For outpatient encounters, CPT 99417 (each additional 15 minutes beyond the time threshold for 99205 or 99215) is used for commercial payers. For Medicare, G2212 serves the same function. Documentation must specify the total time spent on the date of the encounter and the activities performed during prolonged time — reviewing extensive imaging, coordinating multi-specialty care, or counseling patients and families about complex treatment decisions.

High-Volume Neurology ICD-10 Codes

Neurology diagnosis coding requires specificity that goes beyond what many other specialties demand. Payers audit neurology claims for diagnosis-procedure alignment — a nerve conduction study must be linked to a diagnosis that justifies electrodiagnostic evaluation, not just any neurological condition. All codes below are verified HIPAA-valid for 2026.

ICD-10 Code	Description	Clinical Context
G35.A	Relapsing-remitting multiple sclerosis	Most common MS subtype; disease-modifying therapy management
G35.D	Multiple sclerosis, unspecified	Use when subtype not yet determined
G40.909	Epilepsy, unspecified, not intractable, without status epilepticus	Initial seizure workup before classification
G40.802	Other epilepsy, not intractable, without status epilepticus	Classified epilepsy type under ongoing management
G43.909	Migraine, unspecified, not intractable, without status migrainosus	Headache evaluation and treatment
G56.01	Carpal tunnel syndrome, right upper limb	NCS/EMG indication — entrapment neuropathy
G56.02	Carpal tunnel syndrome, left upper limb	NCS/EMG indication — entrapment neuropathy
G62.9	Polyneuropathy, unspecified	EMG/NCS indication — generalized neuropathy workup
G20.A1	Parkinson's disease without dyskinesia, without fluctuations	Movement disorder management
I63.9	Cerebral infarction, unspecified	Acute/post-stroke evaluation and management

 

Note the 2026 update to multiple sclerosis coding: G35 has been expanded with new subcategory codes (G35.A for relapsing-remitting, G35.B1/B2 for primary progressive active/non-active, G35.C0/C1/C2 for secondary progressive). Practices should update from the legacy G35 code to the new specific subcategory codes to improve coding accuracy and support appropriate treatment authorization.

LCD Compliance: Nerve Conduction Studies and EMG

Every Medicare Administrative Contractor maintains an active Local Coverage Determination for nerve conduction studies and electromyography. These LCDs define the covered indications, documentation requirements, and utilization limits that determine whether Medicare will pay for electrodiagnostic testing. Non-compliance with LCD requirements is the leading cause of NCS/EMG claim denials.

LCD ID	Contractor	Title	Effective Date
L36524	Noridian Healthcare Solutions	Nerve Conduction Studies and Electromyography	10/23/2025
L34594	WPS Insurance Corporation	Nerve Conduction Studies and Electromyography	05/29/2025
L35897	CGS Administrators	Nerve Conduction Studies and Electromyography	05/01/2025
L35048	Palmetto GBA	Nerve Conduction Studies and Electromyography	11/14/2024
L34859	First Coast Service Options	Nerve Conduction Studies and Electromyography	12/10/2023
L35081	Novitas Solutions	Nerve Conduction Studies and Electromyography	12/10/2023
L35098	National Government Services	Nerve Conduction Studies and Electromyography	11/21/2019

 

Common LCD Requirements Across MACs

• Specific Clinical Indication: NCS and EMG must be ordered to evaluate a specific clinical question — not as a screening tool. The referral or order must document the signs, symptoms, or differential diagnosis that the electrodiagnostic study is intended to clarify.

• Number of Studies Limitation: Most MACs limit the number of NCS studies to the minimum necessary to answer the clinical question. Bilateral testing is covered only when bilateral symptoms are documented. Testing both upper and lower extremities requires documented symptoms in both regions.
• Physician Supervision: The neurologist must perform the testing personally (for needle EMG) or directly supervise the technologist (for NCS). The interpreting physician must be physically present in the office suite during the testing. Remote interpretation of NCS/EMG does not meet LCD supervision requirements.
• Report Requirements: The electrodiagnostic report must include nerve-by-nerve findings, normal value comparisons, technical adequacy statements, and a clinical interpretation correlating the electrophysiologic data with the patient's clinical presentation.

Injectable Drug Administration in Neurology

Neurology practices administer high-cost injectable medications for conditions including multiple sclerosis, migraine prevention, and movement disorders. Drug administration billing requires both the drug supply code (J-code) and the administration procedure code, each submitted on a separate claim line.

Drug	HCPCS J-Code	Administration CPT	Common Indications
Botulinum toxin A (Botox)	J0585 (per unit)	64615 / 64616	Chronic migraine, cervical dystonia, spasticity
Natalizumab (Tysabri)	J2323	96413 (first hour IV)	Relapsing multiple sclerosis
Ocrelizumab (Ocrevus)	J2350	96413 + 96415 (add-on hrs)	Relapsing and primary progressive MS
Erenumab (Aimovig)	J3032	96372 (SC injection)	Migraine prevention (CGRP inhibitor)
Fremanezumab (Ajovy)	J3031	96372 (SC injection)	Migraine prevention (CGRP inhibitor)
IncobotulinumtoxinA (Xeomin)	J0588 (per unit)	64615 / 64616	Cervical dystonia, blepharospasm

 

Botulinum toxin billing deserves special attention. The J-code is billed per unit, and the number of units varies based on the number of injection sites and clinical protocol. A chronic migraine Botox injection protocol typically requires 155 units across 31 injection sites, generating 155 units of J0585. The injection procedure is billed using 64615 (chemodenervation of muscle(s) of head, face, or neck) or 64616 (chemodenervation of muscle(s) of trunk or extremities). Documentation must specify each muscle injected, the number of units per site, and the total units administered to support the billed quantity.

Neurology Denial Prevention Strategies

Neurology practices face denial rates of 14 to 18 percent, driven primarily by electrodiagnostic LCD non-compliance, medical necessity challenges for advanced imaging, and prior authorization failures for high-cost injectable medications. Systematic denial prevention requires specialty-specific workflows.

1. Pre-Test LCD Verification for EMG/NCS

Before scheduling any electrodiagnostic study, verify that the clinical indication matches the applicable MAC's LCD-covered conditions. Document the specific signs, symptoms, and clinical question in the order and pre-test assessment. If bilateral testing is planned, ensure bilateral symptoms are documented. This single step eliminates the most common category of neurology claim denials.

2. Prior Authorization Tracking for Injectables

High-cost injectable medications almost universally require prior authorization from both commercial payers and Medicare Part B. Build a tracking system that captures the authorization number, approved units, approved frequency, and expiration date for every injectable medication. Verify authorization before every administration — authorizations for chronic medications can be revoked or modified between infusion cycles.

3. Accurate Study Count for NCS Tiered Codes

Overcounting NCS studies pushes the claim to a higher-tier code than supported by the testing performed, creating upcoding risk. Undercounting leaves revenue on the table. Maintain a standardized NCS study counting worksheet that the performing neurologist completes immediately after testing, documenting each motor study, sensory study, F-wave, and H-reflex as discrete units before the coder selects the tiered code.

4. E/M Level Validation for Complex Visits

Neurology encounters frequently qualify for 99215 based on MDM complexity, but documentation must explicitly support all three MDM elements. Implement a pre-billing documentation review for all 99215 claims to verify that the note addresses the number and complexity of problems, data reviewed and analyzed, and risk of management decisions. A 10-second chart review before billing prevents costly post-payment audits.

5. Modifier -59 Usage for Same-Day Testing and E/M

When an E/M visit and electrodiagnostic testing occur on the same date, modifier -25 is appended to the E/M code to indicate a separately identifiable evaluation and management service. Do not use modifier -59 on the E/M code — -59 is reserved for distinct procedural services when NCCI edits would otherwise bundle two procedure codes. Modifier confusion between -25 and -59 is a recurring audit finding in neurology.

Frequently Asked Questions

What CPT codes are used for nerve conduction studies?

NCS codes 95907 through 95913 are tiered by the total number of studies performed per encounter. Each motor nerve, sensory nerve, F-wave, and H-reflex counts as one study. Bill the single code matching the total study count — for example, 95909 for five to six studies. Do not bill individual codes per nerve tested.

Can EMG and NCS be billed on the same date?

Yes. NCS (95907–95913) and needle EMG (95860–95864) are complementary components of a complete electrodiagnostic evaluation and are routinely billed together when medically necessary. No modifier is needed to bill them on the same date. Documentation must support the medical necessity for both types of testing.

What documentation is required for LCD compliance on electrodiagnostic testing?

LCD compliance requires a specific clinical indication documented in the order, signs and symptoms supporting the need for testing, a nerve-by-nerve report with normal value comparisons, physician supervision documentation, and clinical interpretation correlating findings with the patient's presentation. Bilateral testing requires documented bilateral symptoms. Testing must be limited to the minimum number of studies necessary to answer the clinical question.

How do I bill Botox injections for chronic migraine?

Bill the drug supply using J0585 per unit (typically 155 units for the standard chronic migraine protocol) and the injection procedure using CPT 64615 (chemodenervation of head, face, or neck muscles). Document each muscle injected, units per site, and total units. Prior authorization is required by virtually all payers for Botox in chronic migraine.

Do commercial payers still accept consultation codes?

Most major commercial payers — including Blue Cross, UnitedHealthcare, and Aetna — continue to accept and reimburse consultation codes (99242–99245 for office, 99252–99255 for inpatient). Medicare does not accept consultation codes and requires standard E/M codes instead. Always verify with the specific payer before billing consultations, as policies vary by plan.

What ICD-10 codes are new for multiple sclerosis in 2026?

G35 has been expanded with new subcategory codes: G35.A (relapsing-remitting), G35.B1 (active primary progressive), G35.B2 (non-active primary progressive), G35.C0/C1/C2 (secondary progressive variants), and G35.D (unspecified). Practices should update from the legacy G35 code to these specific subtypes for improved coding accuracy and payer authorization support.